Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Seong Hoon Shin"'
Autor:
Bhumsuk Keam, Keon Uk Park, Hye Ryun Kim, Keun-Wook Lee, Sung-Bae Kim, Seong Hoon Shin, Jin-Hyuk Choi, Eun Joo Kang, Yun-Gyoo Lee, Hyo Jung Kim, Min Kyoung Kim, Hwan Jung Yun, Kyoung Eun Lee, Jin-Soo Kim, Hee Kyung Ahn
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose Certain patient subgroups who do not respond to induction chemotherapy (IC) show inherent chemoresistance in locally advanced head and neck squamous cell carcinoma (LA-HNSCC). This study aimed to assess the prognostic value of IC, and role of
Autor:
Hye Ryun Kim, Hyun Chang, Keun-Wook Lee, Myung-Ju Ahn, Seong Hoon Shin, Ho Jung An, Sung-Bae Kim, Sang Hoon Chun, Yun-Gyoo Lee, Ji Hyun Park, Kyoung Eun Lee, In Gyu Hwang, Keon Uk Park, Bhumsuk Keam
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose This study was conducted to determine the effectiveness of immune checkpoint inhibitors (ICIs) in recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) after platinum-containing chemotherapy. We also identified clinical bi
Autor:
Dae Seog Heo, Joo Hang Kim, Jong Seok Lee, Mi Sun Ahn, Yu Jung Kim, Eun Joo Kang, Bhumsuk Keam, Seong Hoon Shin, Se Hyun Kim, Jong Il Kim, Dong Wan Kim, Jin-Soo Kim, Miso Kim, Sook Hee Hong, Tae Min Kim, Sun Min Lim, Sun Wha Im, Chan Young Ock
Publikováno v:
Thoracic Cancer
Background Pulmonary sarcomatoid carcinoma (PSC) is rare with a poor outcome and is resistant to conventional cytotoxic chemotherapy. The efficacy and safety of durvalumab and tremelimumab for treating recurrent or metastatic PSCs were assessed by a
Autor:
Hee Kyung Ahn, Eun Joo Kang, Seong Hoon Shin, Sung-Bae Kim, Y. Lee, Keon Uk Park, Jung Hye Kwon, Kyoung Eun Lee, Keun Wook Lee, Hwan Jung Yun, Hye Ryun Kim, Min Kyoung Kim, Jin-Soo Kim, Jin-Hyuk Choi, Bhumsuk Keam
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer
BMC Cancer
Background By investigating treatment patterns and outcomes in locally advanced head and neck squamous cell carcinoma (LA-HNSCC), we aimed at providing valuable insights into the optimal therapeutic strategy for physicians in real-world practice. Met
Autor:
Hun Mo Ryoo, Yong Sang Hong, Tae Yong Kim, Kyung Hee Lee, Jin Young Kim, Jung Hye Kwon, Ji Yeon Baek, In Gyu Hwang, Myung Ah Lee, Se Hyun Kim, Jin Won Kim, Yoon Ho Ko, Hyun Jung Kim, Soojung Hong, Hyo Jung Kim, Yun Gyoo Lee, Seong Hoon Shin, Jee Hyun Kim, In Sook Woo, Su Jin Koh
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The purpose of this study was to prospectively validate the Korean Cancer Study Group Geriatric Score (KG)-7, a novel geriatric screening tool, in older patients with advanced cancer planned to undergo first-line palliative chemotherapy. Mate
Autor:
Soon-Ock Choi, Jung-Rim Kim, Jeong-Won Baik, Nae-Hyeon Kim, Seong-Hoon Shin, Ji-Seon Ryu, Sook-Nam Kim
Publikováno v:
Asian Nursing Research, Vol 12, Iss 4, Pp 286-292 (2018)
Purpose: This study aimed to evaluate the outcomes of a community-based palliative care project conducted in Busan city, Korea, from 2013 to 2015. Methods: We selected four outcome indices based on the project's outcomes derived from a logic model an
Autor:
In Gyu Hwang, Su Jin Koh, In Sook Woo, Kyung Hee Lee, Jung Hye Kwon, Minsuk Kwon, Jin Won Kim, Sun Young Kim, Myung Ah Lee, Hyun Jung Kim, Sung Hwa Bae, Dong Hoe Koo, Soojung Hong, Seong Hoon Shin, Hyo Jung Kim, Yun Gyoo Lee, Yong Sang Hong, Tae Yong Kim, Se Hyun Kim, Jin Young Kim, Yoon Ho Ko, Jee Hyun Kim
Publikováno v:
Cancers, Vol 13, Iss 331, p 331 (2021)
Cancers
Volume 13
Issue 2
Cancers
Volume 13
Issue 2
Old age alone does not reflect an intolerability to chemotherapy. However, upfront dose reduction (UDR) of the first cycle of first-line palliative chemotherapy has sometimes been chosen by physicians for older adults with metastatic cancer due to co
Autor:
Ji Woong Son, Hwa-Seung Yoo, Seong Hoon Shin, Chulho Oak, Seong Hoon Yoon, Seung Joon Kim, Su Jeong Ha, Jun-Yong Choi, So-Jung Park, Ji Hye Park, Jung A. Kim, Si Yeon Song, Seong Woo Yoon
Publikováno v:
Medicine
Background: Afatinib is an epidermal growth factor receptor - tyrosine kinase inhibitor (EGFR-TKI) with proven efficacy for treating patients with advanced or metastatic non-small cell lung cancer (NSCLC). Unfortunately, responses are limited by acqu
Publikováno v:
Medicine
Background: In recent studies, afatinib, a second-generation inhibitor, showed superior outcomes, when compared to the first-generation of EGFR-tyrosine kinase inhibitors (TKIs), such as erlotinib and gefitinib, in patients with advanced non-small ce
Autor:
So Yeon Oh, Hun Mo Ryoo, Kyung Hee Lee, Moon Hee Lee, Young Jin Choi, Bongseog Kim, Rock Bum Kim, Ho-Suk Oh, So Young Yoon, Joung Soon Jang, Seong Hoon Shin, Yun-Gyoo Lee, Su-Jin Koh, Jung Hun Kang
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 28(11)
To investigate the association between quality of life (QOL) and breakthrough cancer pain (BTCP) intensity in patients who met the commonly accepted definition of BTCP. This study was a subset analysis of a South Korean multicenter, non-interventiona